Morphine affects brain activity and volumes in preterms: An observational multi-center study.


Journal

Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381

Informations de publication

Date de publication:
05 2020
Historique:
received: 13 11 2019
revised: 04 02 2020
accepted: 04 02 2020
pubmed: 11 4 2020
medline: 27 8 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

We hypothesized that morphine has a depressing effect on early brain activity, assessed using quantitative aEEG/EEG parameter and depressed activity will be associated with brain volumes at term in extremely preterm infants. 174 preterm infants were enrolled in 3 European tertiary NICUs (mean GA:26 ± 1wks) and monitored during the first 72 h after birth with continuous 2 channel aEEG. Six epochs of aEEG recordings were selected and minimum amplitude of aEEG (min aEEG), percentage of time amplitude <5 μV (% of time < 5 μV), spontaneous activity transients (SATrate) and interSAT interval (ISI) were calculated. For infants receiving morphine, the cumulative morphine dosage was calculated. In a subgroup of 58 infants, good quality MRI at term equivalent age (TEA) and the cumulative morphine dose until TEA were available. The effects of morphine administration and cumulative dose on aEEG/EEG measures and on brain volumes were investigated. Morphine administration had a significant effect on all quantitative aEEG/EEG measures, causing depression of early brain activity [longer ISI (β 2.900), reduced SAT rate (β -1.386), decreased min aEEG (β -0.782), and increased % of time < 5 μV (β 14.802)] in all epochs. A significant effect of GA and postnatal age on aEEG/EEG measures was observed. Cumulative morphine dose until TEA had a significant negative effect on total brain volume (TBV) (β -8.066) and cerebellar volume (β -1.080). Administration of sedative drugs should be considered when interpreting aEEG/EEG together with the negative dose dependent morphine impact on brain development.

Identifiants

pubmed: 32276190
pii: S0378-3782(19)30610-3
doi: 10.1016/j.earlhumdev.2020.104970
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Morphine 76I7G6D29C

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104970

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors do not report other disclosures.

Auteurs

M L Tataranno (ML)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

L Gui (L)

Division of Development and Growth, Department of Pediatrics, University of Geneva, Geneva, Switzerland.

L Hellström-Westas (L)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

M Toet (M)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

F Groenendaal (F)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

N H P Claessens (NHP)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

J Schuurmans (J)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

V Fellman (V)

Lund University, Department of Clinical Sciences, Lund, Pediatrics, Skåne University Hospital, Lund, Sweden.

K Sävman (K)

Department of Pediatrics, Perinatal Center, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.

L S de Vries (LS)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

P Huppi (P)

Division of Development and Growth, Department of Pediatrics, University of Geneva, Geneva, Switzerland.

M J N L Benders (MJNL)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands. Electronic address: m.benders@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH